Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

"Seed-Milarity" confers to hsa-miR-210 and hsa-miR-147b similar functional activity.

Bertero T, Grosso S, Robbe-Sermesant K, Lebrigand K, Hénaoui IS, Puisségur MP, Fourre S, Zaragosi LE, Mazure NM, Ponzio G, Cardinaud B, Barbry P, Rezzonico R, Mari B.

PLoS One. 2012;7(9):e44919. doi: 10.1371/journal.pone.0044919. Epub 2012 Sep 13.

2.

Functionally orthologous viral and cellular microRNAs studied by a novel dual-fluorescent reporter system.

You X, Zhang Z, Fan J, Cui Z, Zhang XE.

PLoS One. 2012;7(4):e36157. doi: 10.1371/journal.pone.0036157. Epub 2012 Apr 27.

3.

Primary analysis and screening of microRNAs in gastric cancer side population cells.

Zhang HH, Gu GL, Zhang XY, Li FZ, Ding L, Fan Q, Wu R, Shi W, Wang XY, Chen L, Wei XM, Yuan XY.

World J Gastroenterol. 2015 Mar 28;21(12):3519-26. doi: 10.3748/wjg.v21.i12.3519.

4.

Individual microRNAs (miRNAs) display distinct mRNA targeting "rules".

Wang WX, Wilfred BR, Xie K, Jennings MH, Hu YH, Stromberg AJ, Nelson PT.

RNA Biol. 2010 May-Jun;7(3):373-80.

5.

Investigation on tissue specific effects of pro-apoptotic micro RNAs revealed miR-147b as a potential biomarker in ovarian cancer prognosis.

Kleemann M, Bereuther J, Fischer S, Marquart K, Hänle S, Unger K, Jendrossek V, Riedel CU, Handrick R, Otte K.

Oncotarget. 2017 Mar 21;8(12):18773-18791. doi: 10.18632/oncotarget.13095.

6.

Comparison of microRNA profiles of human periodontal diseased and healthy gingival tissues.

Xie YF, Shu R, Jiang SY, Liu DL, Zhang XL.

Int J Oral Sci. 2011 Jul;3(3):125-34. doi: 10.4248/IJOS11046.

7.

Bioinformatics method to predict two regulation mechanism: TF-miRNA-mRNA and lncRNA-miRNA-mRNA in pancreatic cancer.

Ye S, Yang L, Zhao X, Song W, Wang W, Zheng S.

Cell Biochem Biophys. 2014 Dec;70(3):1849-58. doi: 10.1007/s12013-014-0142-y.

PMID:
25087086
8.

Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma.

Liu Q, Chen J, Wang J, Amos C, Killary AM, Sen S, Wei C, Frazier ML.

Mol Carcinog. 2014 Sep;53(9):711-21. doi: 10.1002/mc.22023. Epub 2013 May 9.

9.

[Expression profiles of microRNAs in radioresistant esophageal cell line].

Zheng ZF, Su HF, Zou Y, Peng Z, Wu SX.

Zhonghua Yi Xue Za Zhi. 2011 Mar 8;91(9):639-42. Chinese.

PMID:
21600139
10.

miR-93 suppresses proliferation and colony formation of human colon cancer stem cells.

Yu XF, Zou J, Bao ZJ, Dong J.

World J Gastroenterol. 2011 Nov 14;17(42):4711-7. doi: 10.3748/wjg.v17.i42.4711.

11.

Characterization of microRNA expression profiles in normal and osteoarthritic human chondrocytes.

Díaz-Prado S, Cicione C, Muiños-López E, Hermida-Gómez T, Oreiro N, Fernández-López C, Blanco FJ.

BMC Musculoskelet Disord. 2012 Aug 12;13:144. doi: 10.1186/1471-2474-13-144.

12.

Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi.

Sand M, Skrygan M, Sand D, Georgas D, Gambichler T, Hahn SA, Altmeyer P, Bechara FG.

Cell Tissue Res. 2013 Jan;351(1):85-98. doi: 10.1007/s00441-012-1514-5. Epub 2012 Oct 31.

PMID:
23111773
13.

MicroRNA expression during osteogenic differentiation of human multipotent mesenchymal stromal cells from bone marrow.

Gao J, Yang T, Han J, Yan K, Qiu X, Zhou Y, Fan Q, Ma B.

J Cell Biochem. 2011 Jul;112(7):1844-56. doi: 10.1002/jcb.23106.

PMID:
21416501
14.

Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.

Kanak M, Alseiari M, Balasubramanian P, Addanki K, Aggarwal M, Noorali S, Kalsum A, Mahalingam K, Pace G, Panasik N, Bagasra O.

Appl Immunohistochem Mol Morphol. 2010 Dec;18(6):532-45. doi: 10.1097/PAI.0b013e3181e1ef6a.

PMID:
20502318
15.

Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.

Sand M, Skrygan M, Georgas D, Sand D, Hahn SA, Gambichler T, Altmeyer P, Bechara FG.

J Dermatol Sci. 2012 Dec;68(3):119-26. doi: 10.1016/j.jdermsci.2012.09.004. Epub 2012 Sep 13.

PMID:
23026055
16.

Reprogramming of miRNA networks in cancer and leukemia.

Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM.

Genome Res. 2010 May;20(5):589-99. doi: 10.1101/gr.098046.109.

17.

Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers.

Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L.

Int J Mol Med. 2011 Sep;28(3):327-36. doi: 10.3892/ijmm.2011.714. Epub 2011 Jun 1.

PMID:
21637912
18.

A computational method for predicting regulation of human microRNAs on the influenza virus genome.

Zhang H, Li Z, Li Y, Liu Y, Liu J, Li X, Shen T, Duan Y, Hu M, Xu D.

BMC Syst Biol. 2013;7 Suppl 2:S3. doi: 10.1186/1752-0509-7-S2-S3. Epub 2013 Oct 14.

19.

Expression of regulatory platelet microRNAs in patients with sickle cell disease.

Jain S, Kapetanaki MG, Raghavachari N, Woodhouse K, Yu G, Barge S, Coronnello C, Benos PV, Kato GJ, Kaminski N, Gladwin MT.

PLoS One. 2013 Apr 12;8(4):e60932. doi: 10.1371/journal.pone.0060932. Print 2013.

20.

Identification and characteristics of microRNAs from Bombyx mori.

He PA, Nie Z, Chen J, Chen J, Lv Z, Sheng Q, Zhou S, Gao X, Kong L, Wu X, Jin Y, Zhang Y.

BMC Genomics. 2008 May 28;9:248. doi: 10.1186/1471-2164-9-248.

Supplemental Content

Support Center